Reuters logo
BRIEF-China National Medicines gets regulatory approval for asset acquisition
February 20, 2017 / 11:06 AM / 10 months ago

BRIEF-China National Medicines gets regulatory approval for asset acquisition

Feb 20 (Reuters) - China National Medicines Corp Ltd

* Says it gets securities regulator’s approval for asset acquisition

Source text in Chinese: bit.ly/2kZ2iyO

Further company coverage: (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below